Discover how NGS-based pharmacogenomics improves variant detection and patient safety. Join our webinar on March 10th at 2pm ...

What’s been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news.

Why is sample preparation important? Increasingly, NGS is being asked to handle more challenging samples, from diverse origins, of lower quality or of small size. Before these samples can be analyzed, ...

Illumina’s systems employ short-read sequencing techniques, which has been the predominant NGS technology for the last decade. The company has made huge advances in the NGS space and now markets a ...

Nucleic acid sequencing has become an integral part of modern biomedical research. The advances in sequencing technology, from its invention to modern-day equivalents, have been extraordinary. 2022 ...

Over the last few months, there have been multiple reports on new treatments for sickle cell disease. In this feature, we highlight the biggest updates in this field and think about what the future ...

“Strange is this little animal, because of its exceptional and strange morphology and because it closely resembles a bear en miniature. That is the reason why I decided to call it little water bear.” ...

We’re pleased to announce that registration is now open for The Festival of Genomics, Biodata & AI in Boston this June.

As advancements in genetic technologies accelerate at an astonishing pace, the potential for gene editing to transform our world becomes closer to being realised. With the advent of revolutionary ...

Two things that have defined the 21 st century are genomics and the internet. Through a combination of these has emerged a controversial type of ‘influencer’ on the internet – self-gene-editors or ...

In our most recent Back to Basics feature, we took a look at CRISPR, the gene editing technique that took the world by storm in the early 2010s and continues to dominate the life sciences news cycle.

As technology advances, we’re used to hearing about the latest in a seemingly never-ending list of ‘omics’. With each one hailed as more promising than the last, opportunities in the life sciences ...